APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome

Sitagliptin promotes macrophage-to-faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP-apoB100 transgenic mice

(2012) F. Briand et al.   DIABETES OBESITY & METABOLISM

High-Fat and Fructose Intake Induces Insulin Resistance, Dyslipidemia, and Liver Steatosis and Alters In Vivo Macrophage-to-Feces Reverse Cholesterol Transport in Hamsters

(2012) François Briand et al.   JOURNAL OF NUTRITION

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome

(2011) P. U. Feig et al.   DIABETES OBESITY & METABOLISM

Characterization of Cardiac Size and Function in SHRSP.Z-Leprfa/IzmDmcr Rats, a New Animal Model of Metabolic Syndrome

(2010) Yukari Tada et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The 11- -Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

(2010) J. Rosenstock et al.   DIABETES CARE

Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes

(2010) M. J. Davies et al.   DIABETES OBESITY & METABOLISM

Mouse models of the metabolic syndrome

(2010) A. J. Kennedy et al.   Disease Models & Mechanisms

An animal model of spontaneous metabolic syndrome: Nile grass rat

(2010) Kousuke Noda et al.   FASEB JOURNAL

Selective CETP Inhibition and PPARα Agonism Increase HDL Cholesterol and Reduce LDL Cholesterol in Human ApoB100/Human CETP Transgenic Mice

(2010) Michael K. Hansen et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Influence of Fat and Carbohydrate Proportions on the Metabolic Profile in Patients With Type 2 Diabetes: A Meta-Analysis

(2009) S. Kodama et al.   DIABETES CARE

Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview

(2009) O. Varga et al.   Obesity Reviews

Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice

(2008) José W.A. van der Hoorn et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin

(2008) Willeke de Haan et al.   CIRCULATION